Evidence map›Paper›PMID 22562625›Full record

ArticleClinical reviews in allergy & immunology2012

Cutting-edge issues in autoimmunity and allergy of the digestive system.

Carlo Selmi

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical reviews in allergy & immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Environmental Basis of Autoimmunity.Clinical reviews in allergy & immunology · 2016
    Review
  2. The challenge of treating orphan disease.Clinical reviews in allergy & immunology · 2014
    Article
  3. Clinical spectrum of food allergies: a comprehensive review.Clinical reviews in allergy & immunology · 2014
    Review
  4. Celiac disease as an autoimmune condition.Central-European journal of immunology · 2014
    Review
  5. Autoimmunity in 2012.Clinical reviews in allergy & immunology · 2013
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Carlo SelmiDivision of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA. carlo.selmi@unimi.it

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmunity and allergy involving the digestive system may be considered as paradigmatic for numerous common themes of complex diseases secondary to tolerance breakdown. Among gastrointestinal autoimmune diseases, for example, we encounter diseases in which a clear environmental trigger is identified (i.e., celiac disease), serum autoantibodies are most specific (i.e., primary biliary cirrhosis), or in which the disease pathophysiology is clearly understood (i.e., autoimmune gastritis). Similarly, it is intriguing that the gastrointestinal tract and the liver circulation represent the crucial environment for the development of immune tolerance. This issue is dedicated to the discussion of recent concepts while identifying two major common issues, i.e., the need for serum biomarkers and the role of vitamin D. Other common themes characterize the etiology and effector mechanisms of these and other autoimmune diseases and are discussed in each cutting-edge overview.

Indexed as

AutoimmunityDigestive SystemHumansHypersensitivity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.